Throughout his 35-year career in academia and biotech, Pauwels has pushed the frontiers of high-precision medicine. Starting from a vision on current and future needs, he combines passion, drive, talented co-workers and innovative technologies to bridge the gap between science and the pharmaceutical and diagnostic solutions that reach the market and impact patient lives around the world.
Other positions held by Pauwels include: leader of the Praesens Foundation, which contributes to better epidemic preparedness, early warning and rapid response for existing and emerging infectious diseases; board member of Flanders’ world-leading nano-electronics center imec and the Singaporean Agency for Science, Technology and Research (A*STAR); chairman of miDiagnostics and a board member at the Flanders Institute for Biotechnology (VIB). In 2020, Pauwels was also appointed co-chair of the Diagnostics R&D Working Group of the Access to COVID-19 Tools (ACT) Accelerator.